A close-up shot of a patient's lip during injection procedure.

According to a recent survey from the American Society of Plastic Surgeons, 64% of aesthetic specialists reported a significant increase in patients under 30 seeking facial cosmetic surgery or injectable treatments. This underscores the growing trend toward non-surgical procedures in this age group.

In today’s modern era, younger individuals increasingly opt for minimally invasive injectable treatments to enhance their facial features. Healthcare providers often recommend hyaluronic acid injectables like Revanesse to address facial wrinkles, lines, and lip enhancements.

This article will explore the recommended Revanesse age, the reasons behind these age guidelines, and considerations for treating younger versus older patients.

Key Takeaways

  • This Revanesse age requirement emphasizes that only people in this age range have a well-established safety and effectiveness record for undergoing this injection procedure.
  • The Revanesse manufacturer and the US FDA may have found several reasons for the Revanesse age requirement, like bone structure and metabolism.
  • While Revanesse products are generally safe and well-tolerated by most individuals, there is a consideration in their aesthetic goals that differentiate injection procedures between younger and older patients.
  • Personalized consultations with healthcare providers are crucial to determine suitability and achieve optimal results with tailored treatment plans.

About: Medica Depot is your trusted all-in-one supplier, offering a range of high-quality medical injectables and supplies. Buy Revanesse at Medica Depot today! Whether for health professionals, plastic surgeons, dermatologists, licensed estheticians, or other specialists, we can offer genuine, brand-name products you may need. With Medica Depot, we prioritize serving you better to improve the patient’s quality of life.

FDA-Approved Age Range for Revanesse Treatments

The US FDA approved Revanesse products: Versa+ and Lips+.
Photo Source: Revanesse

Revanesse products have received the US Food and Drug Administration’s approval for their Versa+ and Lips+ hyaluronic acid (HA) dermal fillers. However, only individuals aged 22 years and older can receive these injections for their facial aging skin and lip concerns.

This Revanesse age requirement emphasizes that only people in this age range have a well-established safety and effectiveness record for undergoing this injection procedure. The FDA-approved age range ensures that medical professionals can ensure patient safety and optimal treatment outcomes.

While specific reasons for this chosen age range are unavailable, it’s worth noting that the typical FDA-approved range for these treatments is 18 and above. This treatment may not be suitable for individuals younger than 22 due to its potent components that may cause severe potential risks to younger patients.

Reasons Behind Age Guidelines for Revanesse

The Revanesse manufacturer and the US FDA may have found several reasons for the Revanesse age requirement. These reasons may include physiological and anatomical considerations for different age groups.

  • Bone Structure: Facial bone structure changes over time, influencing filler placement and effectiveness. Younger individuals have a more flexible bone structure that may continuously change until they reach their peak bone mass, making injections not recommended at around 18 to 21 years.
  • Skin Elasticity: As people age, their skin loses elasticity due to decreased collagen and hyaluronic acid production. Younger individuals typically have more resilient skin, making it unsuitable for Revanesse products or other dermal fillers.
  • Tissue Thickness: Skin thickness varies with age. Thicker skin in older adults may require different injection techniques and product formulations.
  • Metabolism: Metabolic rates affect filler longevity. Younger patients metabolize hyaluronic acid more quickly, easily losing the effects.

Additionally, individuals aged 18 to 21 may have yet to have specific concerns about Revanesse under the eye, facial wrinkles, folds, and lip augmentation, which are the approved indications of the Revanesse products. The US FDA guidelines only ensure safety, and adhering to the recommended Revanesse age can help minimize risks.

Considerations for Treating Younger Versus Older Patients

An older individual during a consultation with their aesthetic provider.

While Revanesse products are generally safe and well-tolerated by most individuals, there is a consideration in their aesthetic goals that differentiate injection procedures between younger and older patients.

  • Younger Patients’ Aesthetic Goals and Skin Conditions: These individuals often seek subtle improvements, preventive measures, and minor volume adjustments. Their skin tends to be more flexible, with minor wrinkles and folds and common concerns such as under-eye hollows, lip volume, and contouring.
  • Older Patients’ Aesthetic Goals and Skin Conditions: Individuals opt for facial rejuvenation at an older age. They need addressing for their deeper wrinkles and folds, sagging skin, and volume loss, requiring nasolabial fold injection, lifting, and lip rejuvenation. They often experience collagen loss, thinning, and laxity, which become prevalent as people age.

Understanding these concerns underscores that Revanesse products can more effectively address the problems of older patients due to the unique Revanesse formulation in their injectables. It’s worth noting that adhering to the US FDA guidelines can avoid further complications with younger individuals.

Evidence-Based Recommendations for Age-Appropriate Use of Revanesse

A medical professional administering a patient's facial injection.

Personalized consultations with healthcare providers are crucial to determine suitability and achieve optimal results with tailored treatment plans. Furthermore, a clinical study found that Revanesse Ultra or Versa is safe and comparable in performance to an FDA-approved dermal filler. It effectively corrects facial wrinkles and creases, including nasolabial folds, in patients at least 22 years of age.

Revanesse clinical studies frequently involve individuals in this age range, allowing the US FDA to approve these hyaluronic acid injectables’ safety and effectiveness. Additionally, understanding the age-related factors when using dermal fillers can improve patient safety.

  • Age influences skin texture, elasticity, and volume loss, specifically in the facial region.
  • Tailoring treatment based on age ensures optimal outcomes and patient satisfaction.
  • The skin changes with age, requiring a personalized approach to the injection site, depth, and frequency.

Individuals and medical professionals must understand that personalized treatment plans can ensure safe and effective dermal filler use.

Conclusion

The recommended Revanesse age for treatments is 22 years and older, as approved by the US Food and Drug Administration. This age requirement ensures a well-established safety and effectiveness record for individuals undergoing the injection procedure. Understanding the physiological and anatomical considerations for different age groups further reinforces the importance of adhering to the recommended age limit. 

Furthermore, the considerations for younger versus older patients emphasize the differences in aesthetic goals and skin conditions, highlighting the need for personalized consultations with healthcare providers to determine suitability and achieve optimal results with tailored treatment plans. Abiding by the age guidelines for Revanesse minimizes risks, contributes to patient safety, and ensures favorable treatment outcomes.

FAQs

1. What is the age limit for receiving Revanesse treatments?

The age limit for Revanesse treatments is 22 years and older, as approved by the US FDA for facial aging skin and lip concerns.

2. Why is there an age limit for Revanesse injections?

The age limit is in place to ensure a well-established safety and effectiveness record for individuals undergoing the procedure and to minimize potential risks associated with the treatment’s potent components.

3. Are there specific considerations for younger versus older patients regarding Revanesse treatments?

There are differences in aesthetic goals and skin conditions between younger and older patients, emphasizing the need for personalized consultations with healthcare providers to determine suitability and achieve optimal results with tailored treatment plans.

Require assistance or custom offers?

Our sales representatives are here to help.

BOOK A MEETING

References

  1. Rod Rohrich, M. D. (2017, November 17). Why are millennials getting Botox and fillers in their twenties? American Society of Plastic Surgeons. https://www.plasticsurgery.org/news/blog/why-are-millennials-getting-botox-and-fillers-in-their-twenties
  2. REVANESSE ULTRA PATIENT INFORMATION SHEET. (n.d.). Accessdata.fda.gov. Retrieved July 26, 2024, from https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160042D.pdf